ATE510816T1 - Verfahren zur herstellung von agomelatin - Google Patents

Verfahren zur herstellung von agomelatin

Info

Publication number
ATE510816T1
ATE510816T1 AT09290607T AT09290607T ATE510816T1 AT E510816 T1 ATE510816 T1 AT E510816T1 AT 09290607 T AT09290607 T AT 09290607T AT 09290607 T AT09290607 T AT 09290607T AT E510816 T1 ATE510816 T1 AT E510816T1
Authority
AT
Austria
Prior art keywords
agomelatin
producing
producing agomelatin
Prior art date
Application number
AT09290607T
Other languages
English (en)
Inventor
Christophe Hardouin
Jean-Pierre Lecouve
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE510816T1 publication Critical patent/ATE510816T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/08—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
AT09290607T 2008-08-05 2009-08-04 Verfahren zur herstellung von agomelatin ATE510816T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0804464A FR2934855B1 (fr) 2008-08-05 2008-08-05 Nouveau procede de synthese de l'agomelatine

Publications (1)

Publication Number Publication Date
ATE510816T1 true ATE510816T1 (de) 2011-06-15

Family

ID=40409856

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09290607T ATE510816T1 (de) 2008-08-05 2009-08-04 Verfahren zur herstellung von agomelatin

Country Status (46)

Country Link
US (1) US8143449B2 (de)
EP (1) EP2151429B1 (de)
JP (1) JP5021004B2 (de)
KR (1) KR101127357B1 (de)
CN (1) CN101643431B (de)
AP (1) AP2509A (de)
AR (1) AR074887A1 (de)
AT (1) ATE510816T1 (de)
AU (1) AU2009202905B2 (de)
BR (1) BRPI0903045A2 (de)
CA (1) CA2674764C (de)
CL (1) CL2009001632A1 (de)
CR (1) CR10934A (de)
CU (1) CU23858B1 (de)
CY (1) CY1111573T1 (de)
DK (1) DK2151429T3 (de)
EA (1) EA017684B1 (de)
EC (1) ECSP099549A (de)
ES (1) ES2367236T3 (de)
FR (1) FR2934855B1 (de)
GE (1) GEP20115344B (de)
GT (1) GT200900218A (de)
HK (1) HK1141004A1 (de)
HN (1) HN2009001435A (de)
HR (1) HRP20110568T1 (de)
IL (1) IL199875A (de)
JO (1) JO2821B1 (de)
MA (1) MA31830B1 (de)
ME (1) ME00927B (de)
MX (1) MX2009007971A (de)
MY (1) MY144746A (de)
NI (1) NI200900152A (de)
NZ (1) NZ578381A (de)
PE (1) PE20100259A1 (de)
PL (1) PL2151429T3 (de)
PT (1) PT2151429E (de)
RS (1) RS51740B (de)
SA (1) SA109300498B1 (de)
SG (1) SG158814A1 (de)
SI (1) SI2151429T1 (de)
SV (1) SV2009003344A (de)
TW (1) TWI376365B (de)
UA (1) UA106195C2 (de)
UY (1) UY31985A (de)
WO (1) WO2010015746A1 (de)
ZA (1) ZA200905051B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2011001405A1 (es) 2010-06-10 2012-03-30 Gador S A Conicet Procedimiento para la preparacion de n-[2-(7-metoxi-1-naftil)etil]acetamida, agometalina.
CN102531956B (zh) * 2010-12-21 2014-07-09 浙江九洲药业股份有限公司 用于制备阿戈美拉汀的中间体及相关制备方法
US8561395B2 (en) 2011-03-03 2013-10-22 Tenneco Automotive Operating Company Inc. Poka-yoke mounting system for an exhaust treatment device
EP2562151A1 (de) 2011-08-25 2013-02-27 Dr. Reddy's Laboratories Ltd. Prozesse zur Herstellung von Agomelatin und seine Zwischenstoffe
ITMI20121444A1 (it) 2012-08-27 2014-02-28 Procos Spa Processo per la produzione di agomelatine
FR3014437B1 (fr) * 2013-12-05 2016-12-23 Servier Lab Nouveau procede de synthese de l'agomelatine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DK0781764T3 (da) * 1994-09-06 2000-07-10 Shionogi & Co Fremgangsmåde til fremstilling af alkoxyiminoacetamid-derivater
FR2734816B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine

Also Published As

Publication number Publication date
SG158814A1 (en) 2010-02-26
ZA200905051B (en) 2010-05-26
ME00927B (me) 2012-06-20
CL2009001632A1 (es) 2010-07-19
NI200900152A (es) 2010-03-25
UY31985A (es) 2010-01-29
CU20090131A7 (es) 2011-05-27
MA31830B1 (fr) 2010-11-01
PE20100259A1 (es) 2010-04-10
GEP20115344B (en) 2011-12-12
US8143449B2 (en) 2012-03-27
SI2151429T1 (sl) 2011-09-30
FR2934855A1 (fr) 2010-02-12
DK2151429T3 (da) 2011-09-19
EA200900943A1 (ru) 2010-04-30
CR10934A (es) 2009-10-15
AR074887A1 (es) 2011-02-23
JO2821B1 (en) 2014-09-15
AP2009004929A0 (en) 2009-08-31
EA017684B1 (ru) 2013-02-28
MY144746A (en) 2011-10-31
CY1111573T1 (el) 2015-10-07
ES2367236T3 (es) 2011-10-31
ECSP099549A (es) 2010-03-31
CA2674764A1 (fr) 2010-02-05
KR20100017060A (ko) 2010-02-16
FR2934855B1 (fr) 2010-08-13
AU2009202905A1 (en) 2010-02-25
BRPI0903045A2 (pt) 2010-05-25
WO2010015746A1 (fr) 2010-02-11
JP5021004B2 (ja) 2012-09-05
EP2151429B1 (de) 2011-05-25
TW201018658A (en) 2010-05-16
GT200900218A (es) 2010-08-23
IL199875A0 (en) 2010-05-17
RS51740B (en) 2011-10-31
IL199875A (en) 2013-10-31
SA109300498B1 (ar) 2013-07-23
NZ578381A (en) 2010-11-26
JP2010043078A (ja) 2010-02-25
PT2151429E (pt) 2011-07-11
CU23858B1 (es) 2013-02-26
KR101127357B1 (ko) 2012-04-12
CN101643431A (zh) 2010-02-10
TWI376365B (en) 2012-11-11
AU2009202905B2 (en) 2013-09-05
HN2009001435A (es) 2011-12-27
UA106195C2 (ru) 2014-08-11
HRP20110568T1 (en) 2011-09-30
CA2674764C (fr) 2012-04-17
AP2509A (en) 2012-11-19
MX2009007971A (es) 2010-03-25
US20100036163A1 (en) 2010-02-11
HK1141004A1 (en) 2010-10-29
PL2151429T3 (pl) 2011-11-30
EP2151429A1 (de) 2010-02-10
CN101643431B (zh) 2013-05-15
SV2009003344A (es) 2010-02-05

Similar Documents

Publication Publication Date Title
ATE455105T1 (de) Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten
ATE529527T1 (de) Verfahren zur herstellung von alkoholen
ATE516362T1 (de) Verfahren zur herstellung von biodiesel
ATE527887T1 (de) Verfahren zur herstellung von teeprodukten
ATE548345T1 (de) Verfahren zur herstellung von agomelatin
ATE544086T1 (de) Verfahren zur herstellung von kontaktlinsen
ATE480531T1 (de) Verfahren zur herstellung von benzopyran-2- olderivaten
ATE533747T1 (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
ATE408604T1 (de) Verfahren zur herstellung von 1-alkyl-3- phenyluracilen
ATE535568T1 (de) Verfahren zur herstellung von polyethylenzusammensetzungen
ATE518847T1 (de) Verfahren zur herstellung von betamimetika
ATE516816T1 (de) Verfahren zur herstellung von impfstoffen
DE10799405T8 (de) Verfahren zur herstellung von mangansulfat
ATE523545T1 (de) Verfahren zur herstellung von polyamid
ATE475728T1 (de) Verfahren zur kontinuierlichen herstellung von kohlenstofffasern
DE602007001585D1 (de) Verfahren zur herstellung von kunstlatex
DE602006015090D1 (de) Verfahren zur herstellung von gezielt durchlässigen laminaten
ATE542808T1 (de) Verfahren zur herstellung von epichlorydrin aus glyzerin
ATE546436T1 (de) Verfahren zur herstellung von 2-amino-5- cyanobenzoesäurederivaten
ATE536103T1 (de) Verfahren zur herstellung von hocharomatischem kakao
ATE444303T1 (de) Verfahren zur herstellung von ferrisuccinylcasein
ATE540585T1 (de) Verfahren zur herstellung von tomatenpaste
ATE523483T1 (de) Verfahren zur herstellung von betainen
DE602008006766D1 (de) Verfahren zur herstellung von würzwürfeln
ATE554088T1 (de) Verfahren zur herstellung von pyridoä2,1- aüisochinolinderivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2151429

Country of ref document: EP